CAS 334951-90-5

1H-Indole-6-carboxamide,N-ethyl-2,3-dihydro-N-methyl-2-oxo-3-[phenyl[[4-(1-piperidinylmethyl)phenyl]amino]methylene]-, (3Z)-

CAS: 334951-90-5

Formel: C₃₁H₃₄N₄O₂

Reinheit: 97%

Farbe und Form: Solid

Molekulargewicht: 494.6273

Ref: IN-DA01FS4L

BIBF0775

CAS: 334951-90-5

BIBF0775

Formel: C₃₁H₃₄N₄O₂

Reinheit: ≥98%

Molekulargewicht: 494.63

Ref: 54-BUP12517

BIBF0775

CAS: 334951-90-5

BIBF0775 is a selective TGFβ type I receptor (Alk5) inhibitor (IC50: 34 nM).

Formel: C₃₁H₃₄N₄O₂

Reinheit: 99.45% - 99.79%

Farbe und Form: Solid

Molekulargewicht: 494.63

Ref: TM-T5197

BIBF0775

CAS: 334951-90-5

BIBF0775

Formel: C₃₁H₃₄N₄O₂

Reinheit: 97%

Molekulargewicht: 494.62725

Ref: 54-BISN0074

BIBF0775

CAS: 334951-90-5

(Z)-N-Ethyl-N-methyl-2-oxo-3-(phenyl((4-(piperidin-1-ylmethyl)phenyl)amino)methylene)indoline-6-carboxamide

Formel: C₃₁H₃₄N₄O₂

Reinheit: 97%

Molekulargewicht: 494.63

Ref: IN-DG01101223

BIBF0775

CAS: 334951-90-5

BIBF0775 is a small-molecule inhibitor of the platelet-derived growth factor receptor (PDGFR) that was developed for the treatment of cancer. It binds to the kinase domain of PDGFR and inhibits the activity of this protein. BIBF0775 is active against a number of cancers, including glioma, lung cancer, pancreatic cancer, and prostate cancer. The effective dose has been shown to be 0.1 μM in cells grown in vitro and 10 mg/kg in mice bearing xenograft tumors.

Formel: C₃₁H₃₄N₄O₂

Reinheit: Min. 95%

Molekulargewicht: 494.63 g/mol

Ref: 3D-JNA95190